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Abstract 
 
The formation of lumens in epithelial tissues requires apical-basal polarization of 
cells, and the co-ordination of this individual polarity collectively around a contiguous 
lumen. Signals from the Extracellular Matrix (ECM) instruct epithelia as to the 
orientation of where basal, and thus consequently apical, surfaces should be formed. 
We report that this pathway is normally absent in Calu-3 human lung 
adenocarcinoma cells in 3-Dimensional culture, but that paracrine signals from 
MRC5 lung fibroblasts can induce correct orientation of polarity and acinar 
morphogenesis. We identify HGF, acting through the c-Met receptor, as the key 
polarity-inducing morphogen, which acts to activate b1-integrin-dependent adhesion. 
HGF and ECM-derived integrin signals co-operate via a c-Src-dependent inhibition of 
the RhoA-ROCK1 signalling pathway via p190A RhoGAP. This occurred via 
controlling localization of these signalling pathways to the ECM-abutting surface of 
cells in 3-Dimensional culture. Thus, stromal derived signals can influence 
morphogenesis in epithelial cells by controlling activation and localization of cell 
polarity pathways. 
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1. Introduction 
A simple epithelial monolayer consists of apical-basal polarized epithelial 
cells, which are the basic building block of acini in organs [1]. Epithelial cells possess 
functionally specialized basolateral and apical cell surfaces. The basolateral domain, 
although contiguous, is often described as two independent domains due to their 
distinct functional properties: the basal surface contacts the underlying extracellular 
matrix (ECM) and the lateral surface allows adherence to neighbouring cells, while 
also providing a paracellular diffusion barrier [2]. In contrast, the apical surface 
provides the lining of the lumen of epithelial tissues, possessing the distinct 
characteristic of non-adherence to neighbours or the ECM. Such polarity on an 
individual level must be collectively coordinated between neighbouring cells to form 
the lumen and thus a biological tube.  
 
While the mechanisms of how apical-basal polarity is formed have been 
extensively investigated [1, 2] how such polarity is oriented has until recently been 
neglected [3, 4]. Traditional culture methods for epithelial cells involves growth of 
cells to become apical-basal polarized monolayers on rigid substrata such as glass, 
plastic, or semi-permeable membrane filters. In these systems, the stiff culture 
vessel provides an immediate and strong cue as to where basal membranes should 
form [5]. In contrast, in 3-Dimensional (3D) culture where single epithelial cells are 
embedded in ECM gels, such as Matrigel or collagen, cells are surrounded by ECM. 
In such isotropic conditions, mechanisms must exist to orient apical-basal polarity 
formation such that the basal surface faces the ECM and the apical surface lines the 
cavity of ‘free space’.  
 
We have previously described that temporospatial control of the RhoA 
signalling pathway is essential for the correct orientation of apical-basal polarity [6, 
7]. In the MDCK cyst model, upon embedding isolated MDCK cells into Matrigel gels, 
single cells divide to form a cell doublet that has initially inverted polarity, i.e. apical 
surfaces erroneously facing the ECM. Detection of the ECM by b1-integrin-
dependent adhesion results in phosphorylation of the RhoA-inhibitory GAP p190A 
RhoGAP [6]. P190A leads to inactivation of RhoA-Rho Kinase 1 (ROCK1) signalling, 
at the ECM abutting surface, allowing endocytosis of apical proteins from the ECM-
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abutting periphery and transcytosis to the centre of the cell doublet to form a lumen. 
This results in the correct orientation of apical-basal polarity between cells in 3D 
culture. 
 
An open question from our and others’ previous studies is how generalizable 
signalling pathways identified to regulate polarity orientation in one cell type are to 
other epithelia? In addition, are these pathways defective in epithelial cancer cells? 
In the current work, we show that the previously identified pathway for correct 
polarity orientation is inactive in Calu-3 human lung adenocarcinoma cells grown in 
3D at steady state. Fibroblast-derived Hepatocyte Growth Factor (HGF) can correct 
aberrant polarity orientation in 3D by controlling the localization of polarity pathways 
to the ECM-abutting surface. This suggests that future studies into modulation of this 
pathway may be important for understanding polarity changes in cancer.  
 
2. Materials and Methods 
2.1.2-Dimensional and 3-Dimensional culture. 
3D culture of Calu-3 was performed using adaptations of that described for 
MDCK [6]. Calu-3 (ATCC HTB-55) were grown in Eagle's Minimum Essential 
Medium supplemented with 10% fetal bovine serum (FBS; Gibco). Cell line identity 
and lack of mycoplasma was confirmed (CRUK Beatson Institute). For plating in 3D, 
single cell suspensions were made (2 × 104 cells ml−1) in growth medium 
supplemented with 2% Matrigel (BD Biosciences). Cell:medium:Matrigel mixture was 
plated onto Matrigel-pre-coated (15μl of net Matrigel) 8-well coverglass chambers 
(Nunc, LabTek-II). At appropriate times paraformaldehyde (PFA) was used to fix 
cells. For induction of acinar morphogenesis, cells were treated at day 4 with 
modifiers and fixed at day 9. Modifiers included MRC5 lung-derived fibroblast-
conditioned medium (FCM), HGF blocking antibody (0.1 µg/mL; R&D Systems, 
24612), SU11274 (10 µM; Tocris), HGF (10 ng/ml, gift from Genentech), AIIB2 
(1:200; a gift of C. Damsky, UCSF), TS2/16 (1:100; a gift of C. Damsky, UCSF), PP2 
(5 µM, Sigma-Aldrich, P0042), and Y-27632 (10 µM, Calbiochem, 688002). MRC5 
(ATCC) were cultured in Eagle's Minimum Essential Medium supplemented with 
10% fetal bovine serum (FBS; Gibco). For production of condition medium MRC5 
were grown as previously described [8] to confluence in Eagle's Minimum Essential 
Medium supplemented with 10% fetal bovine serum, 100 U/ml penicillin, 100 mg/ml 
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streptomycin, in tissue culture flasks (T75; Corning). Fresh medium was replaced (30 
ml) before culture for 3 days. Fibroblast conditioned medium was centrifuged at 
3,500 x g to remove cell debris, and frozen at -20°C. 
 
2.2. Antibodies and immunolabelling. 
Calu-3 in 3D culture were stained essentially as described for MDCK cysts [9]. 
Primary antibodies utilized were: Ki-67 (Epitomics, 2642-1), Cleaved Caspase 3 (Cell 
Signaling Technology, 9661L), JAM-A (BD Biosciences, 612120), Muc1 (Epitomics, 
2900-1), GM130 (BD Biosciences, C65120), β-catenin (Santa Cruz, sc-7199), 
NHERF1 (Abcam, ab3452), Ezrin (BD Biosciences, 610603), Cleaved Caspase 8 
(Cell Signaling Technology, 9496), β1-integrin (BD Biosciences, 610467), pY416-c-
Src (Cell Signaling Technology, 6943P), pY1105-p190 (Abcam, ab55339). Alexa 
fluorophore-conjugated secondary antibodies (1:250) or Phalloidin (1:200) (both 
Invitrogen) and Hoechst to label nuclei (10 μg/ml), were utilized. Imaging was 
performed on a Zeiss 510 Confocal Microscope, using a 63x oil immersion lens. 
Image processing was performed using ImageJ. Images shown are representative of 
3 separate experiments. 
 
2.3. Immunoblotting. 
Protein blotting was performed as described [6]. To solubilize cells, cultures 
were washed twice in ice-cold PBS, before addition of ice-cold extraction buffer [50 
mM Tris-HCl pH 7.4, 150 mM NaCl, 0.5 mM MgCl2, 0.2 mM EGTA, and 1% Triton X-
100 plus 50 mM NaF, 1 mM Na3VO4 and complete protease inhibitor cocktail tablet 
(Roche, Mannheim, Germany)]. Lysates were extracted at 4°C for 25 min. For 3D 
cultures a 27½ -gauge needle was used for assisting extraction from ECM. To 
remove debris, centrifugation at 14,000 x g at 4°C for 10 min was performed. 
Samples were separated using SDS-PAGE, and were transferred to PVDF 
membranes. Western analysis was performed using either chemiluminescence 
(SuperSignal Chemiluminescence Kit; Pierce, Rockford, IL) or infrared fluorescent 
secondary antibodies and quantitative detection (Odyssey CLx, Li-COR 
Biosciences). A BCA Protein Assay Reagent kit (Pierce) was used to determine 
protein concentration. Transfer and protein loading were monitored by staining gels 
with 0.1% Coomassie Brilliant Blue. Antibodies for WB were: GAPDH (Millipore, 
MAB374), pY416-c-Src (Cell Signaling Technology, 6943P), total c-Src (Cell 
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Signaling Technology, 2102P), pY1105-p190 (Abcam, ab55339), P190A (BD 
Biosciences, 610149), RhoA (Santa Cruz, sc-418), Phospho-Myosin Light Chain 2 
(Ser19; Cell Signaling Technology, 3671L), ROCK1 (Santa Cruz, sc-17794), ROCK2 
(Santa Cruz Biotechnology, sc-100425). 
 
2.4. RNAi, virus production and transduction. 
Stable depletion of proteins was performed using pLKO.1-puro lentiviral 
shRNA vectors, obtained from the TRC collection. Sequences and clone identities 
are as follows: shScramble (5’-CCTAAGGTTAAGTCGCCCTCG-3’) [10],  
shc-Src_1 (TRCN0000038149, 5’-GCTCGGCTCATTGAAGACAAT-3’), shc-Src_2 
(TRCN0000038150, 5’-GACAGACCTGTCCTTCAAGAA-3’), p190ARhoGAP_1 
(TRCN0000022188, 5’-CGGTTGGTTCATGGGTACATT-3’), p190ARhoGAP_2 
(TRCN0000022184, 5’-GCCCTTATTCTGAAACACATT-3’), shRhoA_1 
(TRCN0000047710, 5’-GTACATGGAGTGTTCAGCAAA-3’), shRhoA_2 
(TRCN0000047711, 5’-TGGAAAGACATGCTTGCTCAT-3’), shROCK1_1 
(TRCN0000121094, 5’-CGGTTAGAACAAGAGGTAAAT-3’), shROCK1_2 
(TRCN0000121095, 5’-GCATTCCAAGATGATCGTTAT-3’), shROCK2_1 
(TRCN0000000978, 5’-GCACAGTTTGAGAAGCAGCTA-3’), shROCK2_2 
(TRCN0000000981, 5’- CCTCAAACAGTCACAGCAGAA-3’).  
 
To produce lentiviral particles, pLKO plasmids were co-transfected with 
Virapower (Invitrogen) lentiviral packaging mix into packaging cells according to 
manufacturer instructions (297-FT, Invitrogen). At time of collection, viral 
supernatants were centrifuged twice at 3500 x g to remove cell debris. Cells were 
transduced with lentiviruses the day after plating, and were infected for 60 hours, 
before selection with puromycin (5 μg/ml, Life Technologies, A11138-03). Efficient 
depletion was verified using Western blotting.  
 
2.5 Adhesion Assay. 
To determine adhesion capability to laminin, 96 well plates were coated with 
10ug/ml laminin-1 (BD, 354239) in PBS+ at 37°C for 30 min. Wells were washed 
with PBS to remove non-bound laminin-1 before blocking of non-coated regions with 
1% BSA solution (SigmaAldrich) in PBS+ for 30 min. Isolated Calu-3 cells were 
seeded at 10,000 cells per well of a 96-well plate (100,000 cells/ml in 100ml per well) 
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in adhesion buffer (HBSS, 10mM HEPES, 2mM Glucose) and incubated for 1 hour. 
Wells were gently washed with PBS to remove unbound cells. Adhesion to the well 
was determined by staining with Calcein AM (Life Technologies) for 5 min, and 
reading for fluorescence in a microplate reader.  
 
2.6 FACS Analysis. 
For quantitation of surface β1-integrin levels, cells were washed twice with 
PBS, trypsinised, centrifuged at 1,500 RPM then re-suspended in 500 µl of FACS 
buffer (PBS+0.1% heat inactivated BSA) and kept on ice. For primary antibody 
labelling with β1-integrin (BD Biosciences, 610467), cells were centrifuged and re-
suspended in 100 µl of FACS buffer containing a 1:200 dilution of primary antibody 
and incubated on ice for 30 min. Cells were washed twice by sequential addition of 1 
ml FACS buffer followed by centrifugation as above. Alexa 488 secondary antibody 
(Thermo Scientific) was added according to the antibody staining as above. Two 
rounds of washing were performed before surface integrin levels were measured 
using a FACS Aria 2 (BD). 
 
2.7 Statistical tests. 
Quantitation of 3D acinus formation was performed as adapted from MDCK 
cultures as previously described [9]. The percentage of acini displaying a single 
central lumen was determined, and compared to control cell aggregates. Values are 
mean ± s.d. from three experiments, with n ≥100 cysts per experiment. Significance 
was calculated using a paired, two-tailed Student’s t-test.  
 
 
3. Results 
3.1 Fibroblast-Conditioned Medium induces acinar polarization of Calu-3 in 3-
Dimesional culture. 
We examined the morphogenesis of a lung adenocarcinoma cell line Calu-3 in 
3-Dimensional (3D) culture, which is thought to be derived from a tumour of the 
bronchial submucosal glands [11]. 3D culture of Calu-3 for up to 9 days in standard 
growth medium (Methods and Materials) failed to induce acinar morphogenesis, 
forming solid multicellular aggregates (Fig. 1A, B). We next examined, the influence 
of soluble factors secreted by an established lung stromal fibroblast cell line (MRC5) 
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on Calu-3 3D morphogenesis. We cultured Calu-3 cells for 9 days, modifying the 
medium by the addition of various factors from days 4-9 (Fig. 1A). Strikingly, 
morphogenetic rearrangements of the Calu-3 cells, resulting in lumen-containing 
acini, could be optimally achieved by changing the culture medium to MRC5 lung 
fibroblast-conditioned medium (FCM) from day 4-9 (Fig. 1A-B). Addition of FCM at 
earlier time points resulted in single cell invasion (data not shown), suggesting that 
aggregates needed to reach a certain size before rearrangement of polarity could 
occur. We thus used this 4+5 day schedule for subsequent experiments. 
 
The first notable event in FCM-induced morphogenesis was the transition of 
cell aggregates from a non-spherical cluster into a sphere by day 5 (d5) (Fig. 1C). 
Subsequently, cells not rearranged into the acinus wall were cleared, concomitant 
with the appearance of a central lumen, and resulting in a cleared and expanded 
lumen by d9. Examination of proliferation (Ki-67) and apoptosis (cleaved caspase-3) 
markers in response to FCM revealed a redistribution of proliferation markers from 
all cells (d4) to solely the acinus wall (d9), while apoptosis could be observed in the 
lumen (d6-8; Fig 1C). FCM-treated acini possess luminal surface localization of the 
apical proteins Muc1, NHERF1 and Ezrin, apically oriented Golgi, and basolateral 
surface b-catenin and JAM-A (Fig. 1D). Without FCM, basolateral protein and Golgi 
orientation appeared randomized, while apical proteins were oriented towards the 
ECM (Fig. 1D). This suggests that FCM caused a polarity reversion accompanied by 
formation of polarized acini. 
 
3.2 HGF is the morphogen in FCM inducing acinar morphogenesis. 
We aimed to determine the morphogenetic factor in FCM that induce Calu-3 
acinar morphogenesis. Hepatocyte Growth Factor (HGF) is a key morphogen that 
MRC5 secrete to induce tubulogenesis of MDCK cysts [8, 12]. Surprisingly, addition 
of HGF alone was sufficient to induce acinus formation by Calu-3 (Fig. 2A, B), 
completely mirroring the effects of FCM. Moreover, signalling by HGF and its 
receptor, c-Met, were both necessary for acinus formation by Calu-3, as addition of 
c-Met inhibitor or HGF blocking antibodies abolished the effects of FCM (Fig. 2A, C). 
HGF-induced morphogenesis mirrored that observed for FCM, converting non-
apoptotic cell aggregates into polarized acini with lumens that display apoptotic 
 9 
remnants, as indicated by the presence of cleaved caspase 3/8 in the lumens of 
acini (Fig. 2B). These data suggest that HGF/c-Met signalling is a key pathway 
activated in Calu-3 by FCM to regulate Calu-3 acinus formation. 
 
3.3 Acinar morphogenesis involves b1-integrin-dependent adhesion and c-Src 
kinase. 
MDCK cells grown in 3D can form either apical-basal polarized cysts 
surrounding a central lumen, or can be induced to form front-rear polarized 
structures with inverted polarity by perturbing signalling from the ECM [9]. We 
examined whether HGF modulates ECM signalling in Calu-3 cells. In 2D culture 
conditions on plastic, Calu-3 grow as loosely adherent aggregates (Fig. 3A). Addition 
of HGF in 2D resulted in morphogenetic rearrangement whereby cells now flattened 
and spread on the plastic substratum. We measured adhesion of freshly plated cells 
to the major ECM component of Matrigel, laminin-1, and found that in contrast to the 
normally low adhesive index of Calu-3, HGF induced strong adhesion of cells (Fig. 
3B). This could be completely blocked by inhibition of b1-integrins, as could steady 
state adhesion levels. Strikingly, activating antibodies to b1-integrins alone were 
sufficient to induce adhesion of Calu-3, to levels above that of HGF alone, and could 
further enhance the effect of HGF (Fig. 3B). These data suggest that HGF may act to 
induce morphogenesis by activating b1-integrin signalling. 
 
b1-integrin similarly controlled 3D morphogenesis. Inhibiting b1-integrins in 3D 
completely blocked the effect of HGF on acinar morphogenesis. Strikingly, activating 
b1-integrin alone was sufficient to induce acinar morphogenesis (Fig. 3C, D). In 3D, 
combined HGF treatment and b1-integrin experimental activation failed to cause 
further acinar morphogenesis, suggesting that each treatment may maximally 
activate b1-integrins in this system. These data suggest that b1-integrins signalling 
pathway may be inactive in Calu-3 at steady state, and activation by HGF or 
antibodies is sufficient to restore 2D adhesion and 3D acinus formation. 
 
We examined the mechanism of HGF-induced b1-integrin function. Using flow 
cytometry from cells from 2D, HGF simulation did not alter the amount of b1-integrins 
on the surface (Fig. 3E), suggesting that presence vs. absence of cortical integrin 
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does not account for the effects of HGF. In 3D, b1-integrin localized to the cell cortex 
in an apparently unpolarised fashion. In contrast, HGF induced a rearrangement of 
polarity such that b1-integrin now localized only to basolateral membranes (Fig. 3F). 
These data suggest that HGF induces cell polarity by triggering the cortical 
asymmetry of b1-integrins solely to the basolateral membrane-ECM interface to 
prompt acinus formation. 
 
To investigate this further we examined a common signalling effector of b1-
integrins, the kinase c-Src [13]. In 2D, HGF stimulation induced activation of c-Src, 
which could be blocked by either a c-Src inhibitor or by blocking b1-integrins (Fig. 
S1A). In 3D, HGF induced a somewhat delayed activation of c-Src, concomitant with 
an increase in total c-Src levels (Fig. 3G). We noted polarization of activated c-Src 
(pY416-c-Src; p-c-Src) similar to b1-integrin in response to HGF, moving from 
general cortical localization to exclusively basolateral membranes (Fig. 3F). c-Src 
was required for HGF induced morphogenesis, as chemical inhibition or the 
depletion of c-Src with either of two shRNAs resulted in a robust inhibition of acinus 
formation in response to HGF (Fig. 3H-J, S1B). c-Src is thus a major target of HGF 
signalling in acinar morphogenesis. 
 
3.4 Inhibition of the RhoA-ROCK1 signalling pathway is required for acinar 
polarization. 
In MDCK cysts, b1-integrin signalling inhibits apical domain formation at the 
ECM-abutting cyst periphery by promoting peripheral phosphorylation of the RhoA-
specific inactivator p190A RhoGAP (hereforth referred to as p190A) [9]. In Calu-3 in 
3D, HGF/c-Src signalling regulated p190A re-localization rather than controlling 
p190A phosphorylation (Fig. 4A, B). In control aggregates, p190A localized to cell-
cell contacts, but was absent from ECM-abutting membranes. HGF induced p190A 
re-localization exclusively to the basolateral domain (Fig. 4A), mirroring that 
observed for b1-integrin and pY416-c-Src (Fig. 3). P190A was required for HGF-
induced acinus formation, as p190A depletion resulted in highly disorganized 
aggregates displaying inverted polarity despite HGF stimulation (Fig. 4C-E). This 
could be rescued by inhibition of Rho Kinase (ROCK1/2) (Fig. 4E), confirming that 
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p190A is acting as an inhibitor of the Rho-ROCK pathway to control polarity 
orientation.  
 
Our data reveal that suppression of the ROCK signalling pathway may be 
sufficient to promote acinus formation in 3D Calu-3. Depletion of RhoA and ROCK1, 
but not ROCK2, was sufficient to induce acinus formation, abolishing the 
requirement for HGF (Fig. 4E-K). ROCK inhibition alone was slightly more potent 
than HGF at inducing acinar polarisation, and combined HGF treatment with ROCK 
inhibition had an additive effect on acinus formation (Fig. S1C). These data suggest 
that HGF activates a c-Src- and b1-integrin-dependent pathway that converges upon 
a RhoA-ROCK1 inhibitory module to control acinus formation. 
 
Together, our data reveal an HGF:c-Met-dependent activation of integrin-
based adhesion to regulate polarity through c-Src:p190A-dependent inhibition of 
RhoA-ROCK1 signalling. As a similar pathway exists in MDCK cysts [6], and the 
correct orientation of polarity can be ‘rescued’ in organoid cultures from patients 
displaying inverted polarity [14], our data suggest a conserved role for p190A, RhoA, 
and ROCK1 in controlling epithelial polarity orientation. 
 
4. Discussion 
In this study, we set out to examine the mechanisms of apical-basal polarity 
orientation pathways in 3D culture. We identified a highly similar pathway of polarity 
orientation in Calu-3 acini as MDCK cysts culture, indicating a conservation of 
polarity mechanisms [6]. In both systems, b1-integrin is required to localize a kinase 
to basolateral membranes to phosphorylate p190A RhoGAP at a site, which brings it 
into a complex with b1-integrins. c-Src and FAK are central to this in both MDCK and 
Calu-3 acini (unpublished observations). This sets up a zone of inhibition against the 
RhoA GTPase at the ECM-abutting membrane of cells, resulting in the inhibition of 
RhoA and its downstream kinase ROCK1. This collectively allows the reorientation of 
apical-basal polarity to form a lumen. 
 
 Most studies examining epithelial polarity almost exclusively utilize isolated 
epithelial cells [15]. Even in such systems the regulation of polarity orientation is only 
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recently becoming clear. In Calu-3 cells in 3D, though the polarity-regulating pathway 
exists and localises to the cell cortex, it does not display the required asymmetry – 
solely to the basolateral domain – to facilitate cell polarisation. This requires 
activation by HGF/c-Met signalling, which can occur upon paracrine signalling by 
fibroblast-derived HGF. The cross-talk between stromal and epithelial compartments 
in a tissue are essential for morphogenesis of both compartments in vivo during 
development and in homeostasis. For instance, during kidney development the 
branching of the ureteric bud is induced by the neighbouring stromal compartment, 
the metanephric mesenchyme, which in turn feeds back on the mesenchyme to 
promote condensation of the stroma to become lumen-containing nephron 
precursors [16]. In addition, in cancer progression, tumours can influence the 
neighbouring stroma, activating it to become cancer-associated fibroblasts, which 
again feedback to promote the progression of tumourigenesis [17]. Such bi-
directional cross talk between the stroma and the epithelium suggests that overall 
tissue architecture is an emergent property of many cell types, each influencing the 
other to regulate collective organisation. It will thus be important in future studies to 
examine co-culture of epithelia with other cell types to determine how these influence 
cell polarity.  
 
The RhoA-ROCK1 signalling pathway is a major regulator of polarity 
orientation [3, 4, 6, 7], and our current and previous results indicate that it must be 
under strict spatiotemporal control to allow for the correct orientation of apical-basal 
polarization. Inhibition of RhoA-ROCK1 signalling appears to be a common 
requirement for robust polarization in 3D contexts, for a growing list of cell types, 
including MDCK cysts [6, 7, 18], Calu-3 as indicated here, and explants of primary 
human intestinal cells [14]. Moreover, ROCK inhibitor is a common component of 
most medium required to establish ex vivo organoid growth and polarisation around 
a central lumen [15, 19]. Whether p190A RhoGAP is the main regulator of this, or 
whether there are many layers of redundancy to ensure inhibition of RhoA-ROCK1 
signalling is unclear. Inhibition of RhoA-ROCK1 does appear to be a generalized 
requirement for efficient lumen formation. 
 
 Given the largely overlapping targets of ROCK1 and ROCK2 [20], it is 
surprising that only ROCK1 inhibition is responsible for polarity reorientation. Our 
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understanding of how ROCK1 antagonises luminal polarisation is incomplete. In the 
MDCK cysts, phosphorylation of the ERM protein Ezrin is a major target controlling 
apical-basal polarity [6]. This regulates where the apical membrane is situated by 
controlling surface localisation of the apical polarity promoting protein Podocalyxin. 
In Calu-3, we were unable to detect Podocalyxin expression (unpublished 
observations), suggesting that alternate Ezrin-binding lumen-promoting proteins may 
be regulated by ROCK1 phosphorylation. Part of the effect of ROCK1 signalling is to 
control tensional status of the actin cytoskeleton by controlling phosphorylation and 
localisation of Myosin-II [7]. Whether Ezrin and Myosin-II are the sole ROCK1 
functional targets regulating lumen formation is unclear. 
 
The morphogenetic rearrangements induced by HGF stimulation, and 
mirrored by ROCK1 inhibition, likely require engagement of the apical polarity 
programme. Lumen formation in diverse contexts requires a complex interplay 
between basolateral polarity complexes (Scribble, Discs Large, Lethal Giant Larvae) 
and the apical complexes (Crumbs/Pals1/PatJ, and Par3-aPKC-Par6-Cdc42) [4]. 
Mutual antagonism between basolateral and apical complexes ensure that 
asymmetry between different subdomains of the cell surface can occur [2]. This 
allows membrane transport to different cortical region [21]. Once established, such 
cortical asymmetry is self-sustained by positive and negative feedback loops. For 
instance, in an apical-basal polarized epithelial cell, both apical and basolateral 
polarity complexes interact with spindle-orientation machinery so that cell divisions 
occur in the plane of the epithelium, ensuring that cells do not divide into the lumen. 
The apical component, aPKC, masterminds this process [4]. Interestingly, aPKC and 
ROCK1/2 exist in antagonism for phosphorylation of Par3 [4]. APKC can 
phosphorylate Par3, which acts to uncouple Par3 from the Cdc42-aPKC-Par6 
complex. However, ROCK-mediated Par3 phosphorylation disrupts aPKC binding to, 
and phosphorylation of Par3, thereby promoting association of Par3-Par6 [22]. 
Conversely, aPKC can phosphorylate ROCKs and control their membrane 
recruitment [23]. The balance between all of these feedback loops controls the 
orientation of cell division [24]. To induce surface asymmetry, some external cue 
must tip the balance towards one end of this mutually antagonistic molecular tug-of-
war. In Calu-3, this function is performed by HGF/c-Met-dependent ROCK1 
inhibition, facilitating basolateral domain formation. ROCK-mediated phosphorylation 
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of Par3 also controls integrin endocytosis [22], and it may control integrin 
rearrangement to the basolateral domain during multicellular polarisation, similar to 
control of integrin polarisation in single cells.  
 
In our system, the transition from aggregate to acinus only occurred if cells 
were cultured in 3D without FCM for at least 4 days. FCM was required for 5 days to 
induce full polarisation and luminal clearance. Addition of FCM before day 4 resulted 
in heterogeneous lumen formation, and in the remainder of cases single cell 
invasion. We hypothesise that polarity rearrangements may only result in a lumen in 
this system if aggregates are of sufficient size to form a lumen between them, via 
apoptosis of non-ECM-abutting cells. In the absence of enough cells, invasion may 
occur. In MDCK cysts, the apical membrane can drive lumen formation or invasion 
into the ECM [6], depending on the status of the aggregates. A similar biphasic 
response to ECM cues here appears to occur based on size.  
 
That HGF can induce acinar polarization of Calu-3 lung adenocarcinoma cells 
is striking, as HGF has been identified as a key factor secreted by lung stroma that 
promotes the survival of lung cancer cells in vivo [25, 26]. Acinar polarization has 
been shown in other systems to promote resistance to cell death-inducing treatments 
[27]. What the functional consequence of promoting acinus formation is for treatment 
for cancer therapies is unknown, but it is tempting to speculate that this may promote 
survival of lung cancer cells, though this possibility awaits future formal testing.   
 
5. Conclusions 
In summary, our data indicate conserved ability of a b1-integrin-p190A 
RhoGAP module in controlling RhoA-ROCK1 signalling for the correct orientation of 
cell polarity. We now demonstrate that whether this pathway is active in cancer cells 
may depend on the cellular context and may be controlled in a non-cell autonomous 
fashion. An unmet need is to understand how to kill residual tumour cells that are 
resistant to inhibition of cell growth pathways. Our work provides a hint that targeting 
polarity pathways might be an unrealised, yet effective route to kill residual, resistant 
cancer cells. 
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Figure Legends 
 
Figure 1:  Fibroblast Conditioned Medium (FCM) induces the formation of 
polarized Calu-3 acini.  
(A) Schematic showing the experimental procedure for developing Calu-3 acini in 3D 
with key modifiers added or removed between days 4-9.   
(B) Calu-3 cells were cultured on a layer of Matrigel in standard growth medium 
containing 2% Matrigel. After 4 days the media on the resultant aggregates were 
either replenished or replaced with FCM. Acini were fixed on day 9, stained with F-
actin and imaged using a confocal microscope.  
(C) Acini were fixed and stained at different time points post addition of FCM at day 
4, with anti-Ki-67 (green), or anti-Cleaved Caspase-3 (magenta) antibodies and with 
Phalloidin (F-actin, black). Arrows indicate the localization of Ki-67. Magnified 
images are also shown (lower panels).  
(D) Untreated aggregates or FCM-treated acini were fixed and stained with Hoechst 
(Nuclei, blue) and either Phalloidin (F-actin), or anti-JAM-A, anti-β-catenin, anti-Muc1 
anti-NHERF-1, anti-Ezrin or anti-GM130 antibodies (all green). Arrows indicate the 
localization of apical proteins. Insets show magnified images.  
All scale bars, 50 µm. 
 
Figure 2: HGF stimulate Calu-3 acinus formation.  
(A) Calu-3 aggregates were treated on day 4 with FCM, HGF (10 ng/ml), FCM + 
HGF blocking monoclonal antibody (HGF mAb; 0.1 µg/mL) or FCM + c-Met Inhibitor 
(SU11274; 10 µM) and fixed on day 9.  Graph shows the number of acini with a 
single central lumen. Results are presented as mean percentage +/- s.d. and 
significance is ***p≤0.0001 (n=3 experiments).  
(B) Aggregates/acini formed in the absence or presence of HGF were fixed and 
stained with either anti-Cleaved Caspase 3 (green in upper panels) or anti-Cleaved 
Caspase 8 antibodies (green in lower panels) and F-actin (red) and Hoechst (blue). 
(C) Calu-3 aggregates were treated on day 4 with FCM, FCM + HGF blocking 
monoclonal antibody (HGF mAb; 0.1 µg/mL) or FCM + c-Met Inhibitor (SU11274; 10 
µM) and fixed on day 9. Staining was performed for F-actin (red) and Nuclei 
(Hoechst, blue).  
All scale bars, 50 µm. 
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Figure 3: c-Src is a major target of HGF signalling in acinar morphogenesis.  
(A) Phase images of Calu-3 cells grown on plastic in presence or absence of HGF.  
(B) Graph shows the relative adhesion of Calu-3 cells adhering to laminin-1 after 
treatment with HGF and either AIIB2, a β1 integrin blocking antibody (1:200), or 
TS2/16, a β1 integrin activating antibody (1:100), all normalized to non-treated 
control cells (NT).  
(C) Control aggregates or aggregates treated with HGF, with TS2/16 or with HGF 
and AIIB2, were fixed and stained with F-actin (red) and Hoechst (blue).  
(D) Graph shows the percentage of acini with a single central lumen upon treatment 
with either control antibody (Co. mAb), HGF, AIIB2 or TS2/16. 
(E) Surface expression of β1-integrin in control and HGF treated Calu-3 cells in 2D 
was examined by FACS analysis.  
(F) Untreated aggregates or HGF-treated acini were fixed and stained with anti-β1 
integrin (green in upper panels) or anti-pY416-c-Src (green in lower panels) 
antibodies and F-actin (red) and Hoechst (blue). A magnified image of anti-β1 
integrin (upper middle panels) and anti-pY416-c-Src (lower middle panels) in 
untreated and HGF treated samples is also shown (a and b respectively).  
(G) Aggregates were stimulated with HGF and harvested at various time-points. 
Immunoblotting was performed using anti-pY416-c-Src, anti-c-Src and anti-GAPDH 
antibodies.  
(H) c-Src protein expression was reduced in Calu-3 cells using either of 2 different 
shRNAs and knockdown confirmed by immunoblotting with anti-c-Src and anti-
GAPDH antibodies.   
(I) Graph shows the percentage of acini with a single central lumen after either 
control of c-Src knockdown and upon HGF stimulation.  
(J) Aggregates expressing Scramble or c-Src shRNA were stimulated with HGF, 
fixed and stained with anti-Muc1 antibody (green), F-actin (red) and Hoechst (blue). 
Arrows indicate localization of Muc1 at membranes. Insets show magnified images 
of Muc1 localization (green).  
Graphs (except 3B) are presented as mean percentage +/- s.d. and significance is 
*p≤0.05 and ***p≤0.0001 (n= 3).  All scale bars, 50 µm. 
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Figure 4: A RhoA-ROCK1 inhibitory module downstream of c-Src and β1 
integrin controls acinus formation.  
(A) Aggregates were treated with HGF, fixed and stained with pY1105-p190A 
RhoGAP antibody (black) and Hoechst (magenta). Magnified images of pY1105-
p190A RhoGAP localization in untreated and HGF stimulated samples (middle 
panels, a and b respectively) are shown.  Red arrows indicate presence or absence 
of pY1105-p190A RhoGAP at the ECM-abutting surface, while green arrows show its 
localization to lateral membranes.  
(B) Aggregates treated with HGF and the c-Src inhibitor PP2 (5 µM), were harvested 
and immunoblotted with anti-pY1105-p190A RhoGAP and anti-GAPDH antibodies. 
(C) P190A RhoGAP expression was reduced in Calu-3 cells using either of 2 
different shRNAs and knockdown confirmed by immunoblotting with anti-p190A 
RhoGAP, anti-pY1105-p190A RhoGAP and anti-GAPDH antibodies.  
(D) Calu-3 aggregates expressing Scramble or p190A RhoGAP shRNA were 
stimulated with HGF then fixed and stained with anti-Muc1 antibody (green), F-actin 
(red) and Hoechst (blue). Arrows indicate localization of Muc1 at membranes. Insets 
show magnified images of Muc1 localization (green).  
(E) Graph shows the percentage of acini with a single central lumen after treatment 
with HGF and Rho Kinase (ROCK1/2) inhibitor, Y-27632 (10 µM).  
(F) RhoA, ROCK1 and ROCK2 were depleted in Calu3 cells using specific shRNAs 
and samples stained with anti-Muc1 antibody (green), F-actin (red) and Hoechst 
(blue).  Arrows indicate localization of Muc1 at membranes.  
(G-I) Knockdown with either of 2 different shRNAs was confirmed by immunoblotting 
with (G) anti-RhoA, (H) anti-ROCK1 and (I) anti-ROCK2 antibodies. GAPDH 
antibody was used as a control.   
(J-K) Graphs show the percentage of acini with a single central lumen after 
knockdown of (J) RhoA or (K) ROCK1 and ROCK2.   
All graphs are presented as mean percentage +/- s.d. and significance is *p≤0.05, 
**p≤0.001  and ***p≤0.0001  (n= 3).  All scale bars, 50 µm. 
 
 
Supplementary Figure 1: Signalling pathways regulating acinar 
morphogenesis.  
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(A) Aggregates were stimulated with HGF and either PP2 (5 µM), AIIB2 (1:200) or 
TS2/16 (1:100).  Immunoblotting was carried out using anti-pY416-c-Src anti-
GAPDH antibodies.  
(B) HGF stimulated aggregates were treated with PP2 and stained with anti-pY416-
c-Src (green) and Hoechst (blue). Insets show magnified images of pY416-c-Src 
(middle panels) in untreated (a) or HGF treated (b) samples.  
(C) Graph shows the percentage of acini with a single central lumen after treatment 
with HGF and ROCK inhibition (Y-27632; 10 µM), either alone or in combination.  
All graphs are presented as mean percentage +/- s.d. and significance is  *p≤0.05,  
**p≤0.001  and ***p≤0.0001  (n= 3).  All scale bars, 50 µm. 
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